Cutaneous Leukocytoclastic Vasculitis Associated with Erlotinib

被引：3
作者：
Sawada, Takahiro [1 ,2 ]
Suehiro, Mitsuhiro [2 ]
Hiranuma, Osamu [3 ]
机构：
[1] Kyoto Prefectural Univ Med, Dept Dermatol, Kamigyo Ku, 465 Kajii Cho, Kyoto, Japan
[2] Otsu Municipal Hosp, Dept Dermatol, 2-9-9 Motomiya, Otsu, Shiga 5200804, Japan
[3] Otsu Municipal Hosp, Dept Resp Med, 2-9-9 Motomiya, Otsu, Shiga 5200804, Japan
来源：
INDIAN JOURNAL OF DERMATOLOGY | 2016年 / 61卷 / 02期
关键词：
D O I：
10.4103/0019-5154.177793
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 5 条
  • [1] Leukocytociastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib
    Boeck, S.
    Wollenberg, A.
    Heinemann, V.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (09) : 1582 - 1583
  • [2] Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?
    Brandi, Giovanni
    Venturi, Michela
    Dika, Emi
    Maibach, Howard
    Patrizi, Annalisa
    Biasco, Guido
    [J]. CUTANEOUS AND OCULAR TOXICOLOGY, 2013, 32 (04) : 336 - 338
  • [3] Successful rechallenge with reduced dose of erlotinib in a patient with lung adenocarcinoma who developed erlotinib-associated leukocytoclastic vasculitis: A case report
    Su, Bo-An
    Shen, Wan-Lin
    Chang, Sheng-Tsung
    Feng, Li-Yia
    Wu, Chia-Jung
    Feng, Yin-Hsun
    [J]. ONCOLOGY LETTERS, 2012, 3 (06) : 1280 - 1282
  • [4] Takahashi Yoko, 2011, Nihon Kokyuki Gakkai Zasshi, V49, P663
  • [5] Yuba Tatsuya, 2010, Nihon Kokyuki Gakkai Zasshi, V48, P81
1